LI
TNGX icon

LRI Investments’s Tango Therapeutics TNGX Stock Holding History

LRI Investments’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.38K Buy
+236
New +$5.83K ﹤0.01% 1049

Other funds holding TNGX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

LRI Investments's TNGX Position: Q2 2026 in Review

LRI Investments opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 236 shares worth $7.38K. The stake represents ﹤0.01% of the portfolio and ranks #1049 among its holdings.

8 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • LRI Investments held 236 shares of Tango Therapeutics worth $7.38K as of Q2 2026.
  • Tango Therapeutics was a new LRI Investments position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1049 holding.
  • 8 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.